Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Charles Schwab | SCHW | Nov 25, 2024 | 81.77 | +0.63 |
Charlton Aria Acquisition Unit | CHARU | Nov 25, 2024 | 9.99 | 0.00 |
Chart Industries | GTLS | Nov 25, 2024 | 189.73 | +3.23 |
Chart Industries | GTLS-B | Nov 25, 2024 | 71.91 | +2.88 |
Charter Communications A | CHTR | Nov 25, 2024 | 384.47 | -0.98 |
Chatham Lodging Trust (REIT) A Pref | CLDT-A | Nov 25, 2024 | 23.30 | -0.98 |
Chatham Lodging Trust REIT | CLDT | Nov 25, 2024 | 9.30 | +0.98 |
Cheche Group | CCG | Nov 25, 2024 | 0.86 | -0.69 |
Check Point Software Technolgies | CHKP | Nov 25, 2024 | 183.18 | +0.79 |
Check-Cap | CHEK | Nov 25, 2024 | 0.82 | -0.54 |
Checkpoint Therapeutics | CKPT | Nov 25, 2024 | 4.03 | +7.47 |
Cheer Holding | CHR | Nov 25, 2024 | 2.46 | +0.41 |
Cheetah Mobile ADR | CMCM | Nov 25, 2024 | 4.99 | +9.67 |
Cheetah Net Supply Chain Service | CTNT | Nov 25, 2024 | 1.91 | +2.69 |
Chegg | CHGG | Nov 25, 2024 | 2.26 | +12.44 |
Chemed | CHE | Nov 25, 2024 | 572.12 | +0.20 |
Chemomab Therapeutics ADR | CMMB | Nov 25, 2024 | 1.63 | -1.21 |
Chemours | CC | Nov 25, 2024 | 21.94 | +1.90 |
Chemung Financial | CHMG | Nov 25, 2024 | 52.46 | +2.06 |
Chenghe Acquisition I Co A | LATG | Nov 25, 2024 | 11.68 | 0.00 |
Chenghe Acquisition I Units | LATGU | Nov 25, 2024 | 11.63 | 0.00 |
Chenghe Acquisition II | CHEB | Nov 25, 2024 | 10.04 | 0.00 |
Cheniere Energy | LNG | Nov 25, 2024 | 218.22 | -1.97 |
Cheniere Energy Partners LP Unit | CQP | Nov 25, 2024 | 54.32 | -0.59 |
Cherry Hill Mortgage Investment | CHMI | Nov 25, 2024 | 2.68 | +5.10 |
Cherry Hill Mortgage Investment A Pref | CHMI-A | Nov 25, 2024 | 22.21 | +2.11 |
Cherry Hill Mortgage Investment B Pref | CHMI-B | Nov 25, 2024 | 23.84 | +0.38 |
Chesapeake Utilities | CPK | Nov 25, 2024 | 133.18 | +0.65 |
Chevron | CVX | Nov 25, 2024 | 160.36 | -1.23 |
Chewy A | CHWY | Nov 25, 2024 | 34.62 | -0.77 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.